Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.
about
The potential for xanthine oxidase inhibition in the prevention and treatment of cardiovascular and cerebrovascular diseaseUric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease?Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian PopulationCardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An updateStatins in heart failure: do we need another trial?Diagnosis and management of the metabolic syndrome in obesityFenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a reviewDo we need a statin-nicotinic acid-aspirin mini-polypill to treat combined hyperlipidaemia?Effects of Three Strong Statins (Atorvastatin, Pitavastatin, and Rosuvastatin) on Serum Uric Acid Levels in Dyslipidemic PatientsThe current role of thiazolidinediones in diabetes management.Associations of non-high density lipoprotein cholesterol and traditional blood lipid profiles with hyperuricemia among middle-aged and elderly Chinese people: a community-based cross-sectional studyA Metabonomics Profiling Study on Phlegm Syndrome and Blood-Stasis Syndrome in Coronary Heart Disease Patients Using Liquid Chromatography/Quadrupole Time-of-Flight Mass SpectrometryA dose-response study of consuming high-fructose corn syrup-sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults.Increased serum levels of uric acid are associated with sudomotor dysfunction in subjects with type 2 diabetes mellitusSerum uric acid and cardiovascular disease.Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis.Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome.Prevention and treatment of the metabolic syndrome.Matrix metalloproteinases and diabetic vascular complications.Secondary prevention of ischemic cerebrovascular disease. What is the evidence?Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences.Improvement in Renal Function and Reduction in Serum Uric Acid with Intensive Statin Therapy in Older Patients: A Post Hoc Analysis of the SAGE Trial.Statins: another class of antihypertensive agents?Serum uric acid as a risk factor for cardiovascular and renal disease: an old controversy revived.Role of xanthine oxidoreductase in cardiac nitroso-redox imbalanceNon-low-density lipoprotein cholesterol-associated actions of ezetimibe: an overview.Gender-related differences in the association between serum uric acid and left ventricular mass index in patients with obstructive hypertrophic cardiomyopathy.Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients.Statins and cardiovascular outcomes in elderly and younger patients with coronary artery disease: a post hoc analysis of the GREACE studyCardiorenal anemia syndrome: do erythropoietin and iron therapy have a place in the treatment of heart failure?Pleiotropic effects of thiazolidinediones.Kidney function and estimated vascular risk in patients with primary dyslipidemiaXanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis.Impact of Statin Therapy on Plasma Uric Acid Concentrations: A Systematic Review and Meta-Analysis.Impact of allopurinol on risk of myocardial infarction.Off target effects of statins shape total mortality?Hyperuricaemia in cardiovascular diseases: a passive or an active player?Effect of statins and ACE inhibitors alone and in combination on clinical outcome in patients with coronary heart disease.Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial.
P2860
Q21342788-97FCB7DE-43E7-42D0-BEA5-5DC33ED3EA98Q24678615-47E4141C-0B8B-4489-A627-802F12065AC3Q26774109-BDB23D0A-A68E-48D5-AAF3-98E3EFB11950Q26997059-5587315A-84EB-4E34-A78F-CC7274080DA6Q26998966-6D10DD4B-A63A-41ED-88FA-B686BFB00DA7Q28192856-6E7F7C1D-A315-42E1-8EF2-F3D01CC4424EQ28220294-4F92B2CC-0D42-4364-9635-6730653A2280Q28222549-A89BACC1-9C22-4828-95D6-8CAA8A5E57D2Q30054768-AEB8AA94-47F9-4B29-B3CD-BFB992888321Q30250347-8817BE81-E94E-4E88-B33C-748AA85F44AAQ33971640-9FD0AD7E-D1A2-4110-952A-F0A635FED064Q34029759-D964C13D-3FF5-42D1-864E-9C698A5572AFQ34473275-6C108AEE-5F8F-4680-98F0-C560522F588CQ35219367-8EA1A2D1-5F58-4A20-A6FC-C3444162EBD1Q35225010-4F81F91D-3CF1-4C23-A87A-0EF2F4B45EA0Q35232279-5972F68C-9737-4EB9-9A6C-7803A0A12246Q35691372-9561EA99-51C1-4887-9E07-86457633CFDDQ35819589-99EFA24E-6146-4C56-88E2-1D3687E950E9Q35952447-BED7583F-DE94-4C66-9E4A-3CF1F0593848Q36081593-B0E2D164-DDEF-4F3F-BB86-F8880D156035Q36271814-D22B3DB9-2709-43FF-B192-0C4BDE3FD150Q36364965-3ECAE2CB-407B-4071-B50D-41C48F5E2433Q36365884-250C931D-EE11-4435-91AF-41F839315313Q36411099-87C561E9-9586-4377-B865-3BF99E55E087Q36540330-F6F3B9EF-5493-4D6B-8F51-094C187CE888Q36557850-C217DD72-7E01-4D3E-BB6E-1C7893A58EB9Q36653658-E3708625-4084-4A4A-946F-20CCA4D86F69Q36769535-141C8A83-20DF-4414-B98D-25A2A8D959EDQ36944127-703419ED-5C90-4B4D-B7B5-1C4D7F5E9FC1Q36984049-F2D0BE7D-B077-4FF5-B542-158CE428521FQ37138777-479F9676-FEAA-4731-B5A0-29EFC0242FE4Q37142044-3A288333-C55D-474A-BC32-D6D0A762CBE7Q37245464-3949739F-13BD-4D2F-BB9B-077DD927A161Q37958283-2CD61EF9-B175-4004-B9B5-F1DB7BDFE8EEQ38853504-4C381337-9A83-410B-AF90-76E15A3F8454Q39033643-22FC90DB-E6B5-4DD0-8147-9B2C0CCE0E49Q41205100-BFCBFB23-6BB8-4B9A-8FCF-5966D7B408B5Q42756654-BA5F2908-5EE6-4FF0-88A3-C0C94B84D2D7Q44960569-4093184C-6039-4544-8A2A-7D1FC459E78AQ44973053-72F20698-91F0-49ED-8908-42CCE79747F2
P2860
Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Effect of statins versus untre ...... ase Evaluation (GREACE) study.
@en
Effect of statins versus untre ...... onary-heart-disease Evaluation
@nl
type
label
Effect of statins versus untre ...... ase Evaluation (GREACE) study.
@en
Effect of statins versus untre ...... onary-heart-disease Evaluation
@nl
prefLabel
Effect of statins versus untre ...... ase Evaluation (GREACE) study.
@en
Effect of statins versus untre ...... onary-heart-disease Evaluation
@nl
P2093
P1476
Effect of statins versus untre ...... ase Evaluation (GREACE) study.
@en
P2093
Anthimos N Pehlivanidis
Athanasios A Papageorgiou
Athanasios N Symeonidis
GREACE Study Collaborative Group
Haralambos J Milionis
Moses Elisaf
Vasilios I Bouloukos
P304
P356
10.1053/J.AJKD.2003.12.023
P577
2004-04-01T00:00:00Z